Impact of early vs. delayed intravenous magnesium sulfate on clinical outcomes in pediatric severe asthma: a retrospective cohort study

BackgroundIntravenous magnesium sulfate (IV MgSO4) is a recommended second-line therapy for children with severe asthma exacerbations unresponsive to initial treatment. While its efficacy in reducing bronchospasm is supported by several studies, the optimal timing of administration in the emergency...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mohammid Alzain, Sajjad Alkhadem, Rafa Alotbi, Ibrahim Alammari, Norah Aljabri, Reem Almijlad, Shahd Abureesh, Hadeel Alharbi, Rawan Alrashed, Yara Algoraini
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-11-01
coleção:	Frontiers in Disaster and Emergency Medicine
Assuntos:	pediatric asthma intravenous magnesium sulfate emergency care PRAM score early intervention asthma exacerbation
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/femer.2025.1689282/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!